Prevalence of GDM and macrosomia in an Argentinian cohort according to ALAD and IADPSG diagnosis criteria

MARÍA INÉS ARGERICH, RAÚL DAVID; MÓNICA ROSANA VIRGA, MÓNICA CHIOCCONI, MARÍA CELESTE GOEDELMANN, PATRICIA GLIKMAN, ALICIA GAUNA, ALEJANDRO HAKIM, SUSANA MARTÍNEZ, GABRIELA MALFETANO, GUSTAVO PINTOS, GABRIELA PORTUNATO, CLAUDIA SCALISE,MARÍA PÍA LOZANO BULLRICH; FABIANA MASJOAN; CAROLINA FARIAS; GABRIELA ROVIRA; STELLA M. SUCANI, MARÍA NATALIA MACCIO, IRENE CONIBERTI, ADRIANA BARTOLIN, ESTRELLA SILVIA ZAMORY; MARÍA LAURA LEWIN, DARÍO AGUERA, ROSANA FULLONE, MERCEDES GARCÍA RICHTER, GRACIELA MURNO, CORINA YANARELLA; SILVIA GORBÁN DE LAPERTOSA, CLAUDIA PARE; MARÍA MARTA CURET; MAGDALENA REY, JOSEFINA BOMARITO,MARÍA PAZ MARTÍNEZ, MAGDALENA MENISES, JOSEFINA POZZO, MARÍA PAULA ESTEBAN, RICARDO H ILLIA, GUILLERMO LOBENSTEIN; SILVANA MANIÁ; CAROLINA FUX OTTA, RODOLFO MENGUAL, LILIANA CERVETTA; JOSÉ MARÍA OCHANDORENA MARTIN, LILIANA PROPATO, SANDRA ROVE¬DA, LORNA GÓMEZ PONCE, MARTA GÓMEZ FLORES; CELINA BERTONA; JORGE ALVARIÑAS, MARÍA CRISTINA FAINGOLD, MYRIAM LILIANA GLATSTEIN, CLAUDIO DANIEL GONZÁLEZ, SUSANA SALZBE

Buenos Aires

Congreso; Scientific Meeting of the International Association of Diabetes and Pregnancy Study Groups 2016 (IADPSG 2016); 2016

GDM diagnosis is a controversial issue. The Argentine Society of Diabetes recommends the use of ALAD guidelines for GDM diagnosis and to perform studies designed to address whether maternal and fetal risks varie according to the GDM diagnostic criteria in our population. The purpose of this work was to evaluate prevalence of macrosomia and GDM following both ALAD and IADPSG criteria in 1037 pregnancies in Argentina. Methods: prevalence of GDM and macrosomia was evaluated in a prospective cohort including 1037 pregnancies, in Argentinian pregnant women. The 1037 pregnant women belong to different Argentinian centers. OGTT (75 g glucose-time 0, 60 min and 120 min) was performed in 24-28 weeks of pregnancy and if negative, repeted in those with risk factors at 31-33 weeks of gestation. For diagnosis and treatment ALAD guidelines were followed: 2 fasting glucose values greater than o equal to 100mg/dl o OGTT values at 120 min post charge greater than or equal to 140 mg/dl, at 60 min greater than or equal to 180 mg/dl or at 120 min greater than or equal to 153 mg/dl.Results: GDM prevalence was 9.86% following ALAD criteria and 24.8% following IADPSG criteria (Kappa coefficient 0.49, p